8-K
Current Report
Grace Therapeutics, Inc. Filed Acc 0001171843-21-006192
Acquisition or sale completed · Shareholder rights changed · Executive or director change · Bylaws or fiscal year change · Shareholder vote results · Regulation FD disclosure
- Item 2.01 Completion of acquisition or disposition of assets
- Item 3.03 Material modification to rights of security holders
- Item 5.02 Departure or appointment of directors or officers
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
- Item 5.07 Submission of matters to a vote of security holders
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading f8k_082721.htm…